Your Shopping Cart Is Empty
| Report Code: A06097 | Mar 2020 | Pages: 206 | ||
| Tables: 83 | Charts: 17 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Veterinary Infectious Disease Diagnostics Market
Request Now !The global veterinary infectious disease diagnostics market was valued at $1,271 million in 2018, and is expected to reach $2,404 million by 2026, registering a CAGR of 8.3% from 2019 to 2026.
Infectious diseases in animals can lead to fatalities if left untreated for long period. Therefore, early diagnosis plays a major role in treatment of animals suffering from these diseases. Furthermore, procedures and tests which are performed to detect the presence of infectious disease is called veterinary diagnosis. In addition, products used in these tests and procedures are called as veterinary infectious disease diagnostics. These diagnostics aid in detection of various infectious disease in animals such as infections caused by viruses, bacteria, and parasites. Moreover, diagnostics can be used in detection of infectious diseases in animals such as cats and dogs
Rise in ownership of companion animals and surge in animal health expenditure are the major factors that boost the growth of the global veterinary infectious disease diagnostics market. For instance, diagnosis of animal ailments require a considerable amount of funds. Number of consumers who are willing to spend more and are seeking for such services has increased. In addition, increase in prevalence of various infectious diseases among companion animals significantly drives the growth of the veterinary infectious disease diagnostics market. However, lack of awareness related to the use of veterinary infectious disease diagnostics in underdeveloped countries restricts the veterinary infectious disease diagnostics market growth. On the contrary, surge in awareness related to animal healthcare across the globe is expected to offer remunerative opportunities for market expansion during the forecast period.
Veterinary Infectious Disease Diagnostics Market Segmentation
The global veterinary infectious disease diagnostics market size is studied on the basis of product type, application, and region. On the basis of product type, it is segmented into immunodiagnostics, molecular diagnostics, and others. By application, it is classified into dogs, cats, and others. By region, it is analyzed across North America (the U.S, Canada, and Mexico) and Europe (Germany, France, Italy, the UK and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
By product type, the immunodiagnostics segment acquired the largest share of the veterinary infectious diseases market in 2018. Furthermore, the segment is expected to grow at the fastest rate during the forecast period due to factors such as surge in the prevalence of infectious diseases in animals. Furthermore, other factor that contribute to the growth of the market include rise in animal healthcare expenditure. In addition, benefits associated with the use of these tests is another factor that fuels the growth of the veterinary infectious disease diagnostics market. For instance, lateral flow assays provide rapid results and sensitive & accurate diagnosis, which makes them a preferred choice. In addition, other benefits include low sample volume, low cost, and user-friendly operation. Therefore, aforementioned factors contribute to the growth of veterinary infectious disease diagnostics market.
By application, the dogs segment acquired the major share of the global veterinary infectious disease diagnostics market and is expected to exhibit the fastest growth rate during the forecast period, owing to surge in ownership of dogs as companion animals worldwide. Furthermore, surge in awareness related to dog health among their owners is another major factor that augments the growth of this segment.
On the basis of region, North America acquired a major share, owing to easy availability of veterinary infectious disease diagnostic products in the region, surge in pet ownership, and increase in animal healthcare expenditure. The other major factor that contributes toward the growth of this market include rise in incidences of various diseases related to animals. However, Europe is expected to grow at the highest rate during the forecast period, due to surge in awareness related to animal health among owners. In addition, presence of majority of key players in Europe boosts the growth of the market in this region. Some of the key players operating in the Europe veterinary infectious disease diagnostics market include Virbac., Randox Laboratories Ltd, ID.Vet, and Biomérieux SA. Therefore, this leads to easy availability of veterinary infectious disease diagnostics in the region, which fuels the growth of the market
The global veterinary infectious disease diagnostics market is highly competitive and the prominent players in the market have adopted various strategies for garnering maximum veterinary infectious disease diagnostics market share. These include collaboration, product type launch, partnership, and acquisition. Major players operating in the market include Biomérieux SA, HESKA Corporation, IDEXX Laboratories, Inc., ID.Vet, Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac, and Zoetis.
Veterinary Infectious Disease Diagnostics Market Report Highlights
| Aspects | Details |
|---|---|
| By Product Type |
|
| By Application |
|
| By Region |
|
| Key Market Players | Neogen Corporation, Virbac., IDEXX Laboratories, Inc., Randox Laboratories Ltd, THERMO FISHER SCIENTIFIC INC, QIAGEN N.V., Heska Corporation, ID.Vet, Zoetis, bioMérieux SA |
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Thereat of new entrants
3.3.4. Threat of substitutes
3.3.5. Intensity of competitive rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in ownership of companion animals
3.4.1.2. Rise in animal health expenditure
3.4.1.3. Increase in demand for pet insurance
3.4.2. Restraint
3.4.2.1. Lack of veterinary infrastructure facilities in underdeveloped nations
3.4.3. Opportunity
3.4.3.1. Surge in awareness related to animal healthcare
3.4.4. Impact Analysis
CHAPTER 4: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Immunodiagnostics
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Molecular Diagnostics
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Others
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Dogs
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Cats
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market analysis, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. market size and forecast, by product type
6.2.2.1.2. U.S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by product type
6.2.2.2.2. Canada market size and forecast, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico market size and forecast, by product type
6.2.2.3.2. Mexico market size and forecast, by application
6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by application
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market analysis, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by product type
6.3.2.1.2. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by product type
6.3.2.2.2. France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by product type
6.3.2.3.2. UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by product type
6.3.2.4.2. Italy market size and forecast, by application
6.3.2.5. Rest of Europe
6.3.2.5.1. Rest of Europe market size and forecast, by product type
6.3.2.5.2. Rest of Europe market size and forecast, by application
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market analysis, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by product type
6.4.2.1.2. Japan market size and forecast, by application
6.4.2.3. China
6.4.2.3.1. China market size and forecast, by product type
6.4.2.3.2. China market size and forecast, by application
6.4.2.4. India
6.4.2.4.1. India market size and forecast, by product type
6.4.2.4.2. India market size and forecast, by application
6.4.2.5. Rest of Asia-Pacific
6.4.2.5.1. Rest of Asia-Pacific market size and forecast, by product type
6.4.2.5.2. Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market analysis, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil market size and forecast, by product type
6.5.2.1.2. Brazil market size and forecast, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia market size and forecast, by product type
6.5.2.2.2. Saudi Arabia market size and forecast, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa market size and forecast, by product type
6.5.2.3.2. South Africa market size and forecast, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA market size and forecast, by product type
6.5.2.4.2. Rest of LAMEA market size and forecast, by application
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. bioMérieux SA
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Heska Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. IDEXX Laboratories, Inc.
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Product portfolio
7.3.1. Business performance
7.4. ID.Vet
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. Neogen Corporation
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. QIAGEN N.V.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Randox Laboratories Ltd
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Key strategic moves and developments
7.8. THERMO FISHER SCIENTIFIC INC
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Virbac.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Zoetis
7.10.1. Company overview
7.10.2. Operating business segments
7.10.3. Product portfolio
7.10.4. Business performance
LIST OF TABLES
TABLE 01. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2016–2026 ($MILLION)
TABLE 02. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2018–2026 ($MILLION)
TABLE 03. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHERS MARKET, BY REGION 2018–2026 ($MILLION)
TABLE 05. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY APPLICATION, 2016–2026 ($MILLION)
TABLE 06. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY REGION, 2018–2026 ($MILLION)
TABLE 07. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY REGION, 2018–2026 ($MILLION)
TABLE 08. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 09. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 11. U.S. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 12. U.S. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 13. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 14. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 15. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 16. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 17. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 18. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 19. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 21. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 22. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 23. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 24. UK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 25. UK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 26. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 27. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 28. REST OF EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 29. REST OF EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 30. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 31. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 33. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 34. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 36. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 37. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 38. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39. REST OF ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 40. REST OF ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 41. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 42. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 43. LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 44. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 45. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 46. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 47. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 48. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 49. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 50. REST OF LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 51. REST OF LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 52. LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 53. LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. BIOMÉRIEUX: COMPANY SNAPSHOT
TABLE 55. BIOMÉRIEUX: OPERATING SEGMENTS
TABLE 56. BIOMÉRIEUX: PRODUCT PORTFOLIO
TABLE 57. HESKA: COMPANY SNAPSHOT
TABLE 58. HESKA: PRODUCT SEGMENTS
TABLE 59. HESKA: PRODUCT PORTFOLIO
TABLE 60. IDEXX.: COMPANY SNAPSHOT
TABLE 61. IDEXX.: OPERATING SEGMENTS
TABLE 62. IDEXX.: PRODUCT PORTFOLIO
TABLE 63. ID.VET: COMPANY SNAPSHOT
TABLE 64. ID.VET: OPERATING SEGMENTS
TABLE 65. ID.VET: PRODUCT PORTFOLIO
TABLE 66. NEOGEN: COMPANY SNAPSHOT
TABLE 67. NEOGEN: OPERATING SEGMENTS
TABLE 68. NEOGEN: PRODUCT PORTFOLIO
TABLE 69. QIAGEN: COMPANY SNAPSHOT
TABLE 70. QIAGEN: OPERATING BUSINESS SEGMENTS
TABLE 71. QIAGEN: PRODUCT PORTFOLIO
TABLE 72. RANDOX: COMPANY SNAPSHOT
TABLE 73. RANDOX: OPERATING BUSINESS SEGMENTS
TABLE 74. RANDOX: PRODUCT PORTFOLIO
TABLE 75. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 76. THERMO FISHER SCIENTIFIC: OPERATING BUSINESS SEGMENTS
TABLE 77. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 78. VIRBAC: COMPANY SNAPSHOT
TABLE 79. VIRBAC: OPERATING SEGMENTS
TABLE 80. VIRBAC: PRODUCT PORTFOLIO
TABLE 81. ZOETIS: COMPANY SNAPSHOT
TABLE 82. ZOETIS: PRODUCT BUSINESS SEGMENTS
TABLE 83. ZOETIS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE COMPETITIVE RIVALRY
FIGURE 09. U.S. PET INDUSTRY EXPENDITURE, 2007–2017 ($BILLION)
FIGURE 10. IMPACT ANALYSES
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHERS MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. U.S. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 18. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 19. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 20. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 21. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 22. UK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 23. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 24. REST OF EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 25. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 26. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 27. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 29. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 30. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 31. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 32. REST OF LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2018–2026 ($MILLION)
FIGURE 33. BIOMÉRIEUX: NET SALES, 2016–2018 ($MILLION)
FIGURE 34. HESKA: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. HESKA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. HESKA: REVENUE SHARE BY REGION, 2018(%)
FIGURE 01. IDEXX: NET SALES, 2016–2018 ($MILLION)
FIGURE 02. IDEXX: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 03. IDEXX: REVENUE SHARE BY REGION, 2018(%)
FIGURE 04. NEOGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 05. NEOGEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 06. QIAGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 07. QIAGEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 08. QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 09. THERMO FISHER SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 10. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 11. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 12. VIRBAC: NET SALES, 2016–2018 ($MILLION)
FIGURE 13. VIRBAC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 14. VIRBAC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 15. ZOETIS: NET SALES, 2016–2018 ($MILLION)
FIGURE 16. ZOETIS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 17. ZOETIS: REVENUE SHARE BY REGION, 2018(%)
Veterinary infectious disease diagnostics are products which are used to identify and detect the presence of viral, bacterial, parasitic, and other type of infections in animals. Furthermore, there are different types of veterinary infectious disease diagnostics available in the market such as immunodiagnostics, molecular diagnostics, and others, which are used in detection of infectious diseases in animals such as cats, dogs, guinea pigs, and rabbits.
Moreover, factors such as rise in adoption of companion animals and surge in animal healthcare expenditure contribute to the growth of the veterinary infectious disease diagnostics market. In addition, factors such as rise in awareness related to animal health among their owners is another factor that fuels the growth of the market.
Furthermore, the market in North America is on the rise, owing to factors such as easy availability of veterinary infectious disease diagnostics and presence of key players. In addition, Europe is anticipated to register highest growth during the forecast period, owing to factors such as rise in research related to new veterinary infectious disease diagnostics and surge in awareness related to the use of these diagnostics.
A. The total market value of veterinary infectious disease diagnostics market is $1,270.50 million in 2018.
A. The forcast period for veterinary infectious disease diagnostics market is 2019 to 2026
A. The market value of veterinary infectious disease diagnostics market in 2019 is $1,376.00 million.
A. The base year is 2018 in veterinary infectious disease diagnostics market
A. Top companies such as, QIAGEN N.V., Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Virbac., and Zoetis held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Immunodiagnostics segment is the most influencing segment owing to surge in the prevalence of infectious diseases in animals. Furthermore, other factors that contribute to the growth of the market include rise in animal healthcare expenditure
A. The major factor that fuels the growth of the global veterinary infectious disease diagnostics market includes surge in pet ownership across the world which led to surge in awareness towards animal healthc among pet owners.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 11.7%. This is due to increased pet ownership and surge in awareness associated with early diagnosing and treatment of diseases prevalent among companion animals.
A. Veterinary infectious disease diagnosticss are products used in procedures conducted to test the presence of infectious diseases in animals. There are different types of veterinary infectious diseases diagnostics present in the market such as immunodiagnostics, molecular diagnostics and others.
A. Veterinary infectious disease diagnostics are employed to detect the presence of viruses and bacteria in animal such as giardiasis and coccidiosis in dogs and others.
Start reading instantly.
This Report and over 68,113+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report